Histogram
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Visit (Number)
Baseline (BL) | Clinical Evaluation (CE) | Diagnostic Visit (DX) | CPAP Titration Visit (CPAP) | Two Month Post-CPAP Neurocognitive Visit (2M) | Four Month Post-CPAP Neurocognitive Visit (4M) | Six Month Post-CPAP Neurocognitive Visit (6M) | |
---|---|---|---|---|---|---|---|
Total | 1,516 | 1,516 | 1,516 | 1,516 | 1,516 | 1,516 | 1,516 |
Non-randomized | 411 | - | - | - | - | - | - |
Group A - Sham | 547 | - | - | - | - | - | - |
Group A - Active | 558 | - | - | - | - | - | - |
Unknown | - | 1,516 | 1,516 | 1,516 | 1,516 | 1,516 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Gender
Baseline (BL)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
Non-randomized | 235 | 176 | 411 |
Group A - Sham | 359 | 188 | 547 |
Group A - Active | 364 | 194 | 558 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Gender
Clinical Evaluation (CE)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
Non-randomized | - | - | - |
Group A - Sham | - | - | - |
Group A - Active | - | - | - |
Unknown | 958 | 558 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Gender
Diagnostic Visit (DX)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
Non-randomized | - | - | - |
Group A - Sham | - | - | - |
Group A - Active | - | - | - |
Unknown | 958 | 558 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Gender
CPAP Titration Visit (CPAP)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
Non-randomized | - | - | - |
Group A - Sham | - | - | - |
Group A - Active | - | - | - |
Unknown | 958 | 558 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Gender
Two Month Post-CPAP Neurocognitive Visit (2M)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
Non-randomized | - | - | - |
Group A - Sham | - | - | - |
Group A - Active | - | - | - |
Unknown | 958 | 558 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Gender
Four Month Post-CPAP Neurocognitive Visit (4M)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
Non-randomized | - | - | - |
Group A - Sham | - | - | - |
Group A - Active | - | - | - |
Unknown | 958 | 558 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Gender
Six Month Post-CPAP Neurocognitive Visit (6M)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
Non-randomized | - | - | - |
Group A - Sham | - | - | - |
Group A - Active | - | - | - |
Unknown | 958 | 558 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Race/Ethnicity
Baseline (BL)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Non-randomized | 10 | 28 | 69 | 39 | 261 | 4 | 411 |
Group A - Sham | 10 | 27 | 47 | 46 | 415 | 2 | 547 |
Group A - Active | 8 | 34 | 56 | 31 | 426 | 3 | 558 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Race/Ethnicity
Clinical Evaluation (CE)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Non-randomized | - | - | - | - | - | - | - |
Group A - Sham | - | - | - | - | - | - | - |
Group A - Active | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Race/Ethnicity
Diagnostic Visit (DX)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Non-randomized | - | - | - | - | - | - | - |
Group A - Sham | - | - | - | - | - | - | - |
Group A - Active | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Race/Ethnicity
CPAP Titration Visit (CPAP)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Non-randomized | - | - | - | - | - | - | - |
Group A - Sham | - | - | - | - | - | - | - |
Group A - Active | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Race/Ethnicity
Two Month Post-CPAP Neurocognitive Visit (2M)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Non-randomized | - | - | - | - | - | - | - |
Group A - Sham | - | - | - | - | - | - | - |
Group A - Active | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Race/Ethnicity
Four Month Post-CPAP Neurocognitive Visit (4M)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Non-randomized | - | - | - | - | - | - | - |
Group A - Sham | - | - | - | - | - | - | - |
Group A - Active | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Treatment Group (0= Non-randomized; 1) Group A = Sham; 2) Group B = Active) vs Race/Ethnicity
Six Month Post-CPAP Neurocognitive Visit (6M)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Non-randomized | - | - | - | - | - | - | - |
Group A - Sham | - | - | - | - | - | - | - |
Group A - Active | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |